The microbiota regulates susceptibility to fas-mediated acute hepatic injury

Laboratory Investigation

Volumn 94, Issue 9, 2014, Pages 938-949

  Celaj, Stela ^a   Gleeson, Michael W ^a   Deng, Jie ^a   O'Toole, George A ^a   Hampton, Thomas H ^a   Toft, Martin F ^b   Morrison, Hilary G ^c   Sogin, Mitchell L ^c   Putra, Juan ^d   Suriawinata, Arief A ^d   Gorham, James D ^a,d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Taconic Farms Inc   (United States)

^c MARINE BIOLOGICAL LABORATORY   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CONCANAVALIN A; FAS ANTIGEN; METRONIDAZOLE; MYELOID DIFFERENTIATION FACTOR 88; NEOMYCIN; RNA 16S; TOLL LIKE RECEPTOR; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL LOAD; CLOSTRIDIA; COMMENSAL; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXPERIMENTAL MOUSE; FECES MICROFLORA; FEMALE; GERMFREE ANIMAL; IMMUNOCOMPETENT CELL; INJURY SEVERITY; INTESTINE FLORA; LIVER CELL; LIVER INJURY; MICROBIOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; RUMINOCOCCACEAE; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD95; DISEASE SUSCEPTIBILITY; FEMALE; FLOW CYTOMETRY; LIVER DISEASES; MICE; MICE, INBRED BALB C; MICROBIOTA; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION;

EID: 84906827149     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.93     Document Type: Article

References (50)

1. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metageno mic sequencing. Nature 2010;464:59-65.
2. Chassaing B, Etienne-Mesmin L, Gewirtz AT. Microbiota-liver axis inhepatic disease. Hepatology 2014;59:328-339.
3. Henao-Mejia J, Elinav E, Thaiss CA, Licona-Limon P, Flavell RA. Role ofthe intestinal microbiome in liver disease. J Autoimmun 2013;46:66-73.
4. Carvalho FA, Aitken JD, Vijay-Kumar M, Gewirtz AT. Toll-like receptor gut microbiota interactions: Perturb at your own risk! Annu RevPhysiol 2012;74:177-198.
5. Szabo G, Bala S, Petrasek J, Gattu A. Gut-liver axis and sensingmicrobes. Dig Dis 2010;28:737-744.
6. Ojiro K, Ebinuma H, Nakamoto N, Wakabayashi K, Mikami Y, Ono Y,et al. MyD88-dependent pathway accelerates the liver damage ofConcanavalin A-induced hepatitis. Biochem Biophys Res Commun2010;399:744-749.
7. Lin Y, Yu L-X, Yan H-X, Yang W, Tang L, Zhang H-L, et al. Gut-derivedlipopolysaccharide promotes T-cell-mediated hepatitis in micethrough Toll-like receptor 4. Cancer Prev Res (Phila) 2012;5:1090-1102.
8. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, et al.Hepatic ischemia/reperfusion injury involves functional TLR4 signalingin nonparenchymal cells. J Immunol 2005;175:7661-7668.
9. Jiang W, Sun R, Zhou R, Wei H, Tian Z. TLR-9 activation aggravatesconcanavalin A-induced hepatitis via promoting accumulation andactivation of liver CD4\+ NKT cells. J Immunol 2009;182:3768-3774.
10. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M,Sutterwala FS, et al. Acetaminophen-induced hepatotoxicity in mice isdependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest2009;119:305-314.
11. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liverinjury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
12. Nakamoto N, Ebinuma H, Kanai T, Chu P-S, Ono Y, Mikami Y, et al.CCR9\+ macrophages are required for acute liver inflammation inmouse models of hepatitis. Gastroenterology 2012;142:366-376.
13. Hatada S, Ohta T, Shiratsuchi Y, Hatano M, Kobayashi Y. A novelaccessory role of neutrophils in concanavalin A-induced hepatitis. Cell Immunol 2005;233:23-29.
14. Tagawa Y, Kakuta S, Iwakura Y. Involvement of Fas/Fas ligand systemmediatedapoptosis in the development of concanavalin A-inducedhepatitis. Eur J Immunol 1998;28:4105-4113.
15. Cripps JG, Wang J, Maria A, Blumenthal I, Gorham JD. Type 1 T helpercells induce the accumulation of myeloid-derived suppressor cells inthe inflamed Tgfb1 knockout mouse liver. Hepatology 2010;52:1350-1359.
16. Upadhyay V, Poroyko V, Kim T-J, Devkota S, Fu S, Liu D, et al.Lymphotoxin regulates commensal responses to enable diet-inducedobesity. Nat Immunol 2012;13:947-953.
17. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al.Induction of intestinal Th17 cells by segmented filamentous bacteria.Cell 2009;139:485-498.
18. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, et al. Entericsalmonellosis disrupts the microbial ecology of the murinegastrointestinal tract. Infect Immun 2008;76:907-915.
19. Eren A. M, Vineis J. H, Morrison H. G, Sogin M. L. A filtering method togenerate high quality short reads using Illumina Paired-EndTechnology. PLoS ONE 2013;8:e66643.
20. Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG,et al. Unique microbial communities persist in individual cystic fibrosispatients throughout a clinical exacerbation. Microbiome 2013;1:27.
21. Küsters S, Gantner F, Künstle G, Tiegs G. Interferon gamma plays acritical role in T cell-dependent liver injury in mice initiated byconcanavalin A. Gastroenterology 1996;111:462-471.
22. Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, Watanabe H, et al.Requirement of IL-4 and liver NK1\+ T cells for concanavalinA-induced hepatic injury in mice. J Immunol 1997;159:1537-1542.
23. Yan S, Wang L, Liu N, Wang Y, Chu Y. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis.Immunol Cell Biol 2012;90:421-428.
24. Seino K, Kayagaki N, Takeda K, Fukao K, Okumura K, Yagita H.Contribution of Fas ligand to T cell-mediated hepatic injury in mice.Gastroenterology 1997;113:1315-1322.
25. Ivanov II, Frutos R de L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB,et al. Specific microbiota direct the differentiation of IL-17-producingT-helper cells in the mucosa of the small intestine. Cell Host Microbe2008;4:337-349.
26. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al.Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337-341.
27. Fuhrer A, Sprenger N, Kurakevich E, Borsig L, Chassard C, Hennet T.Milk sialyllactose influences colitis in mice through selective intestinalbacterial colonization. J Exp Med 2010;207:2843-2854.
28. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, et al.Commensal microbiota and myelin autoantigen cooperate to triggerautoimmune demyelination. Nature 2011;479:538-541.
29. Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE,et al. Intestinal microbiota in patients with nonalcoholic fatty liverdisease. Hepatology 2013;58:120-127.
30. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, et al.Host response to translocated microbial products predicts outcomesof patients with HBV or HCV infection. Gastroenterology 2011;141:1220-1230, 1230.e1-3.
31. French SW. Mechanisms of alcoholic liver injury. Can J Gastroenterol2000;14:327-332.
32. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbialexposure during early life has persistent effects on natural killer T cellfunction. Science 2012;336:489-493.
33. Wei B, Wingender G, Fujiwara D, Chen DY, McPherson M, Brewer S,et al. Commensal microbiota and CD8\+ T cells shape the formationof invariant NKT cells. J Immunol 2010;184:1218-1226.
34. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K.Critical contribution of liver natural killer T cells to a murine model ofhepatitis. Proc Natl Acad Sci USA 2000;97:5498-5503.
35. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, et al.Augmentation of Valpha14 NKT cell-mediated cytotoxicity byinterleukin 4 in an autocrine mechanism resulting in the developmentof concanavalin A-induced hepatitis. J Exp Med 2000;191:105-114.
36. Ubeda C, Lipuma L, Gobourne A, Viale A, Leiner I, Equinda M, et al.Familial transmission rather than defective innate immunity shapesthe distinct intestinal microbiota of TLR-deficient mice. J Exp Med2012;209:1445- 1456.
37. Wu H-J, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gutresidingsegmented filamentous bacteria drive autoimmune arthritisvia T helper 17 cells. Immunity 2010;32:815-827.
38. Kriegel MA, Sefik E, Hill JA, Wu H-J, Benoist C, Mathis D. Naturallytransmitted segmented filamentous bacteria segregate with diabetesprotection in nonobese diabetic mice. Proc Natl Acad Sci USA2011;108(28):11548-11553.
39. Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI,et al. Mucolytic bacteria with increased prevalence in IBD mucosaaugment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010;105:2420-2428.
40. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K,Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patientswith Crohn's disease and their unaffected relatives. Gut 2011;60:631-637.
41. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z,et al. A pyrosequencing study in twins shows that gastrointestinalmicrobial profiles vary with inflammatory bowel disease phenotypes.Gastroenterology 2010;139:1844-1854.e1.
42. O'Toole A, Alakkari A, Keegan D, Doherty G, Mulcahy H, O'Donoghue D.Primary sclerosing cholangitis and disease distribution in inflammatorybowel disease. Clin Gastroenterol Hepatol 2012;10:439-441.
43. Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS,Zinsmeister AR, et al. PSC-IBD: A unique form of inflammatory boweldisease associated with primary sclerosing cholangitis. Gut2005;54:91-96.
44. Hoskins LC, Boulding ET. Degradation of blood group antigens inhuman colon ecosystems. I. In vitro production of ABH blood groupdegradingenzymes by enteric bacteria. J Clin Invest 1976;57:63-73.
45. Hoskins LC, Boulding ET. Mucin degradation in human colonecosystems. Evidence for the existence and role of bacterialsubpopulations producing glycosidases as extracellular enzymes.J Clin Invest 1981;67:163-172.
46. Desbarats J, Newell MK. Fas engagement accelerates liverregeneration after partial hepatectomy. Nat Med 2000;6:920-923.
47. Matsuki Y, Li L, Hsu H-C, Yang PA, Zheng R, Edwards CK, et al. SolubleFas gene therapy protects against Fas-mediated apoptosis ofhepatocytes but not the lethal effects of Fas-induced TNF-alphaproduction by Kupffer cells. Cell Death Differ 2002;9:626-635.
48. Liedtke C, Trautwein C. The role of TNF and Fas dependent signalingin animal models of inflammatory liver injury and liver cancer. Eur J Cell Biol 2012;91:582-589.
49. Song E, Lee S-K, Wang J, Ince N, Ouyang N, Min J, et al. RNAinterference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9:347-351.
50. Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, et al.Caspase 8 small interfering RNA prevents acute liver failure in mice.Proc Natl Acad Sci USA 2003;100:7797-7802.